According to the current shareholder structure, MedLife holds the majority stake - 60% - and Mihai Pavel, the group's founder, holds 40%.
In H2 2024, MedLife recorded consolidated pro forma revenue of RON 1.3 billion, up 24% compared to H1 2023, likely to exceed half a €500 million in revenue this year.
The new partnership will accelerate MedLife Group's development in the use of the latest genetic sequencing methodologies and technologies in routine diagnostics.
With 138 deal announcements in 2024, Romania has seen a 6% increase in deal volume from the previous year.
MOL Group's profit before tax (PBT) down by 23% year on year almost entirely due to external environmental impacts,
The company currently has a market share of between 7% and 15% in certain product segments, with a target of 3% growth over the next two years.
Romania, the main strategic partner of the Republic of Moldova – Reconfirmation by the visit of Prime Minister Dorin Recean to Terra Impex in the Vulcănești Free Economic Zone.
The transaction is financed through the NextGenerationEU program, with the financial support of the Government of Romania and the Government of Bulgaria, through the PNRR.